Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
---|---|---|---|---|---|---|---|
Primex-40 | |||||||
Ambadi Investments Limited |
Particulars |
31-03-2024 |
31-03-2023 |
Assets |
|
|
Cash and Cash Equivalents |
597.98 |
584.04 |
Bank Balances other than cash and cash equivalents |
442.64 |
718.63 |
Investments accounted using equity method |
10,46,441.84 |
8,42,264.69 |
Other Investments |
10,250.92 |
8,270.62 |
Trade Receivables |
3,904.20 |
3,480.45 |
Other Financial Assets |
643.16 |
607.01 |
Inventories |
4,279.21 |
4,005.35 |
Current Tax Assets |
473.13 |
608.84 |
Biological Assets |
55.61 |
42.62 |
Property, Plant and Equipment |
8,334.43 |
8,731.68 |
Capital Work-in-Progress |
778.81 |
734.66 |
Right of use assets |
548.71 |
579.16 |
Intangible Assets |
14.53 |
7.01 |
Other Non-Financial Assets |
1,044.72 |
1,430.16 |
Total Assets |
10,77,809.89 |
8,72,064.92 |
LIABILITIES |
|
|
Trade Payables |
|
|
Total outstanding dues of Micro and Small Enterprises |
37.50 |
25.54 |
Total outstanding dues to other than Micro and Small Enterprises |
4,542.42 |
4,357.51 |
Borrowings (Other than Debt Securities) |
1,085.22 |
1,642.33 |
Lease liabilities |
640.63 |
628.00 |
Other Financial Liabilities |
538.77 |
487.08 |
Current Tax Liabilities |
75.80 |
- |
Provisions |
1,763.40 |
1,981.70 |
Deferred Tax Liabilities |
302.45 |
469.62 |
Other Non financial liabilities |
832.75 |
1,161.85 |
EQUITY |
|
|
Equity Share Capital |
244.30 |
244.30 |
Other Equity |
1,65,261.59 |
8,58,475.09 |
Equity Attributable to Owners of the Company |
10,65,505.89 |
8,58,719.39 |
Non Controlling Interest |
2,455.06 |
2,591.90 |
Total Equity and Liabilities |
10,77,779.89 |
8,72,064.92 |
Particulars |
31-03-2024 |
31-03-2023 |
Revenue from Operations |
|
|
Dividend income |
3.94 |
3.79 |
Net Gain - fair value changes on Mutual Funds |
73.79 |
57.97 |
Interest Income from Investments - Bonds |
486.00 |
96.14 |
Sale of Products / Services |
39,192.04 |
40,214.47 |
Other Operating Revenues |
879.07 |
723.07 |
Other Income |
637.82 |
687.05 |
Total Income |
41,272.66 |
41,782.49 |
Expenses |
|
|
Cost of Materials Consumed |
9,583.94 |
10,486.96 |
Purchase of Stock-in-Trade |
8,347.64 |
9,898.32 |
Changes in Inventories of Finished Goods, Work-in-Progress and |
-202.89 |
-167.00 |
Changes in Biological Assets |
-12.99 |
-8.90 |
Employee Benefits Expense |
13,170.18 |
11,648.42 |
Depreciation and Amortisation Expense |
901.67 |
959.30 |
Finance Costs |
263.80 |
260.70 |
Other Expenses |
9,118.35 |
8,697.38 |
Total Expenses |
41,169.70 |
41,775.18 |
Profit Before Share of Profit / (Loss) from Associates and Tax |
102.96 |
7.31 |
Share of Profit / (Loss) from Associates |
1,71,531.96 |
1,42,403.79 |
Profit Before Tax |
1,71,634.92 |
1,42,411.10 |
Current Tax |
1,691.45 |
1,268.72 |
MAT Credit Entitlement |
-69.42 |
- |
Deferred Tax (Net) |
19.69 |
182.66 |
Profit for the year |
1,69,993.20 |
1,40,959.72 |
Other Comprehensive Income: |
|
|
Remeasurement of the defined benefit plans |
36.70 |
-113.10 |
Net (loss)/gain in Fair value in Equity Instruments |
-1,213.70 |
-133.15 |
Income Tax Effect |
186.86 |
10.66 |
Share of Other Comprehensive Income of Associates |
2,597.64 |
-2,671.75 |
Share of Other Comprehensive Income of Associates |
1,279.19 |
361.88 |
Total Comprehensive Income for the Year, Net of Tax |
1,72,879.89 |
1,38,414.26 |
Profit for the year attributable to : |
|
|
Owners of the Company |
1,70,049.49 |
1,41,004.98 |
Non-Controlling Interest |
-56.29 |
-45.25 |
Other Comprehensive Income for the year attributable to : |
|
|
Owners of the Company |
2,955.08 |
-2,500.81 |
Non-Controlling Interest |
-68.39 |
-44.65 |
Total Comprehensive Income for the year attributable to : |
|
|
Owners of the Company |
1,73,004.57 |
1,38,504.16 |
Non-Controlling Interest |
-124.68 |
-89.90 |
Earnings Per Equity Share of 10/- each |
|
|
Basic |
6,960.62 |
5,771.74 |
Diluted |
6,960.62 |
5,771.74 |
Particulars |
31-03-2024 |
31-03-2023 |
Cash Flow from Operating Activities: |
|
|
Profit Before Tax |
1,71,634.92 |
1,42,411.10 |
Adjustments to reconcile Profit Before Tax to Net Cash Flows: |
|
|
Depreciation on Property, Plant and Equipment |
901.67 |
959.30 |
Interest Income received |
-63.85 |
-47.88 |
Profit on Property Plant & Equipment sold/discarded (Net) |
4.57 |
8.84 |
Profit on Sale of Investments |
-73.27 |
-57.68 |
Provision / (Reversal of Provision) for Trade Receivables (Net) |
35.95 |
7.42 |
Compensation received towards land acquisition from Government of Assam |
- |
-575.56 |
Share of Profit from Associate |
-1,71,531.96 |
-1,42,403.79 |
Profit on Sale of current Investments |
-14.86 |
-7.16 |
Fair Value changes in current investments |
-31.45 |
-12.40 |
Finance Costs |
263.80 |
260.70 |
Liabilities/Provisions no longer required written back |
-433.25 |
-9.59 |
Provision for Contingency / Leave Encashment / Gratuity |
52.65 |
63.66 |
Impact of Foreign Currency Translation |
-15.73 |
-17.33 |
Dividend Income |
10,941.68 |
9,240.22 |
Operating Profit before Working Capital / Other Changes |
11,670.87 |
9,819.85 |
Adjustments for : |
|
|
(Increase) / Decrease in operating Financial Assets |
-472.40 |
837.92 |
(Increase) / Decrease in operating Non-Financial Assets |
20.30 |
-196.81 |
Increase / (Decrease) in Financial Liabilities |
265.05 |
-405.49 |
Increase/(Decrease) in Non-Financial Liabilities |
145.11 |
559.16 |
Cash Generated From Operations |
11,338.71 |
10,614.63 |
Income Tax paid |
-1,612.23 |
-1,228.98 |
Net Cash Flow from Operating Activities |
9,726.48 |
9,385.65 |
Cash Flow from Investing Activities: |
|
|
Capital Expenditure (Including Capital Work In Progress and Capital Advances) |
-257.60 |
-1,531.39 |
Proceeds from Sale of Property, Plant and Equipment |
26.75 |
29.55 |
Sale/(Purchase) of Current Investments (Net) |
-234.14 |
1,072.10 |
Purchase of Non Current Investments |
-3,411.91 |
-3,999.69 |
Proceeds from sale of shares of Non Current Investment |
471.50 |
- |
Decrease in other bank balances not considered as cash and cash equivalents |
261.68 |
218.72 |
Interest Income received |
46.28 |
41.52 |
Dividend received |
0.04 |
2.36 |
Net Cash Used in Investing Activities |
-3,097.40 |
-4,166.83 |
Cash Flow from Financing Activities: |
|
|
Proceeds from Long Term Borrowings |
- |
347.43 |
Repayment of Long Term Borrowings |
-372.11 |
-300.00 |
Proceeds from Short Term Borrowings (Net) |
-194.02 |
-190.00 |
Payment of Lease Liabilities |
-27.12 |
-31.21 |
Finance Costs Paid |
-263.35 |
-261.20 |
Dividends Paid |
-5,688.55 |
-4,833.50 |
Net Cash Used in Financing Activities |
-6,545.15 |
-5,268.48 |
Net Decrease in Cash and Cash Equivalents |
83.94 |
-49.65 |
Cash and Cash Equivalents at the Beginning of the Year |
484.04 |
533.69 |
Cash and Cash Equivalents as at End of the Year |
567.98 |
484.04 |
Cash and Cash Equivalents as per Balance Sheet |
567.98 |
584.04 |
Less: Deposits with Banks |
- |
100.00 |
Cash and Cash Equivalents as per cash flow statement |
597.98 |
484.04 |
Here is a summary of the Cash Flow Statement for the years 2024 and 2023:
Cash Flow from Operating Activities: The company generated a net cash flow of ₹9,726.48 lakhs from operating activities, an increase from ₹9,385.65 lakhs in the previous year. This rise is primarily due to higher operating profit before working capital changes, which increased from ₹9,819.85 lakhs to ₹11,670.87 lakhs. Adjustments, including higher dividend income and lower compensation received towards land acquisition, contributed to this improvement. However, this was partially offset by a decrease in operating financial assets and increased tax payments.
Cash Flow from Investing Activities: The cash used in investing activities decreased to ₹3,097.40 lakhs from ₹4,166.83 lakhs. The significant capital expenditure in the prior year, amounting to ₹1,531.39 lakhs, was reduced to ₹257.60 lakhs this year. Additionally, there was a positive shift with proceeds from the sale of non-current investments and a decrease in net purchase of current investments. Despite these improvements, high purchases of non-current investments and low dividend income from investments impacted the cash flows.
Cash Flow from Financing Activities: Net cash used in financing activities increased to ₹6,545.15 lakhs from ₹5,268.48 lakhs. This rise was due to higher dividend payments and repayments of long-term borrowings, partially offset by proceeds from short-term borrowings. The increase in finance costs and dividends paid also contributed to the higher cash outflow.
Net Decrease in Cash and Cash Equivalents: Overall, there was a net increase in cash and cash equivalents of ₹83.94 lakhs compared to a decrease of ₹49.65 lakhs in the previous year. Cash and cash equivalents at the end of the year amounted to ₹567.98 lakhs, reflecting an increase from ₹484.04 lakhs in the previous year. This improvement in cash position indicates a positive cash flow despite the higher outflows in financing activities.